$HGEN News Article - Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta (Axicabtagene Ciloleucel) with Lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
https://marketwirenews.com/news-releases/kite...77292.html